myCOPD应用程序用于管理慢性阻塞性肺病:一个好的医疗技术指南为数字健康技术的指南
Heather Davies1, Mary Chappell2, Yingying Wang3
1York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, YO10 5NQ, York, UK. Heather.r.davies@york.ac.uk.
Applied health economics and health policy
|May 28, 2023
概括
myCOPD是慢性阻塞性肺病 (COPD) 管理的数字工具,显示了急性恶化和肺部康复的潜在成本节约. 需要进一步的证据来证实其在COPD护理中的有效性和成本效益.
科学领域:
- 数字卫生技术数字卫生技术
- 卫生经济学 卫生经济学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 管理面临着重大的医疗保健挑战.
- 数字工具为患者的自我管理和康复提供了潜在的解决方案.
- myCOPD是一个数字平台,旨在支持COPD患者.
研究的目的:
- 评估myCOPD对治疗COPD的临床和经济影响.
- 评估myCOPD在两个特定患者亚组的成本效益:急性恶化和肺部康复.
- 为英国国家卫生和护理卓越研究所 (NICE) 的指导提供信息.
主要方法:
- 对证据的系统审查,包括三项随机对照试验 (RCT) 和观察数据.
- 为COPD急性恶化 (AECOPD) 和肺部康复 (PR) 患者群体开发新的经济模型.
- 与标准护理相比,分析每个临床委托组 (CCG) 的成本节约.
主要成果:
- myCOPD证明了AECOPD患者每次CCG的潜在成本节约为86,297英,PR患者每次CCG的潜在成本节约为22,779英.
- 预计该工具将在AECOPD的74%的代中节省成本,在PR的86%中节省成本.
- 临床研究的样本大小小,限制了统计能力和可比性.
结论:
- myCOPD显示出作为一个数字工具来管理COPD在成年人的承诺.
- 需要进一步的证据来解决关于其有效性和长期影响的不确定性.
- 尼斯指南 (MTG68) 承认潜力,但强调需要更可靠的数据.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:26COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K